000 | 01690 a2200529 4500 | ||
---|---|---|---|
005 | 20250513202532.0 | ||
264 | 0 | _c20000316 | |
008 | 200003s 0 0 eng d | ||
022 | _a0040-5957 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAnsar, M | |
245 | 0 | 0 |
_aIsomers of substituted 3-benzo[b]furyl and 3-thienylaminobutyric acids as potent ligands of the GABA-B receptor: synthesis and preparative liquid chromatographic separation. _h[electronic resource] |
260 |
_bTherapie _c |
||
300 |
_a651-8 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAminobutyrates _xchemical synthesis |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBaclofen _xmetabolism |
650 | 0 | 4 | _aBinding, Competitive |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aGABA Agonists _xchemical synthesis |
650 | 0 | 4 |
_aGABA Antagonists _xchemical synthesis |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aMuscimol _xmetabolism |
650 | 0 | 4 |
_aNerve Tissue Proteins _xdrug effects |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aReceptors, GABA-B _xdrug effects |
650 | 0 | 4 | _aStereoisomerism |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xmetabolism |
700 | 1 | _aEbrik, S | |
700 | 1 | _aMouhoub, R | |
700 | 1 | _aVaccher, C | |
700 | 1 | _aVaccher, M P | |
700 | 1 | _aFlouquet, N | |
700 | 1 | _aBakkas, S | |
700 | 1 | _aTaoufik, J | |
700 | 1 | _aDebaert, M | |
700 | 1 | _aCaignard, D H | |
700 | 1 | _aRenard, P | |
700 | 1 | _aBerthelot, P | |
773 | 0 |
_tTherapie _gvol. 54 _gno. 5 _gp. 651-8 |
|
999 |
_c10621551 _d10621551 |